Escalon(R) Announces China Registration for Sonomed PacScan(R) and E/Z-Scan(R) Series of A-scan, Pachymeter and B-Scan Systems
WAYNE, Pa., April 3, 2008 /PRNewswire-FirstCall/ -- Escalon Medical
Corp. (Nasdaq: ESMC ) today announced that its Sonomed, Inc. subsidiary
received approval from the State Food and Drug Administration within the
People's Republic of China to market the PacScan(R) and E/Z-Scan(R) series
Escalon(R) Reports Third Quarter Fiscal 2009 Results
...business units, highlighted by 33.8% at Drew, primarily related to the acquisition of JAS Diagnostics in May 2008 and Biocode Hycel in December 2008. sonomed
and EMI product revenue increased 1.1% and 32.5%, respectively.
For the third quarter of fiscal 2009, the Company reported a net loss of $(683,...
Escalon(R) Reports Second Quarter Fiscal 2009 Results
...second quarter product revenue growth at its Drew, sonomed
and Vascular business units of approximately 19%, ...crease in research and development expenses in the sonomed
and EMI business segments.
Expanded Product ...ithin the region. For the 2009 six month period, sonomed
product revenue increased $370,000, or 7.8%, to $5...
Escalon(R) Reports First Quarter Fiscal 2009 Results
...was primarily related to increased research and
development expenses at the sonomed
division for the development of three
new products. Operating expenses also...oaden our product
portfolio. Increased research and development expenses at sonomed
resulted in the development of three new products. We expect that thes...
Escalon(R) Reports First Quarter Fiscal 2008 Results
...period. This decrease was primarily due to decreased sales at the
and Vascular business units, which decreased 3% and 2%,
respectively, compa...r sale in the
United States in the second quarter of fiscal 2008." "At our sonomed
business unit, product revenue was $2,233,000 a
decrease of approximately $...
Escalon(R) Reports Financial Results for 2007 Fiscal Year
...uct revenue increase was primarily related to strong
sales in the Company's sonomed
and Escalon Digital Solutions ("EMI")
business units, which increased appro...ased to be report another successful year for Escalon Medical.
Overall, our sonomed
business had an excellent fiscal 2007 driven by
increased sales of the new ...
Escalon(R) Announces FDA 510(k) Clearance for Sonomed MASTER-VU(TM) B-Scan System
WAYNE, Pa., Jan. 3 /PRNewswire-FirstCall/ -- Escalon Medical Corp.
(Nasdaq Capital Market: ESMC) today announced that its Sonomed, Inc.
subsidiary received 510(k) clearance from the U.S. Food and Drug
Administration (FDA) to market the MASTER-VU(TM) ophthalmic B-scan
ultrasound system. The MAS...
Escalon(R) Reports Third Quarter Fiscal 2008 Results
...000, or 12%, primarily due to sales of the new D3
instrument, and increased reagent revenues generated from Drew's United
"At our sonomed
business unit, we delivered an increase of 12% in
product revenue, realizing increased sales of our VuMax(R) II and E-Z
Scan(TM) A/B Scan ultrasound s...
Escalon(R) Reports Second Quarter Fiscal 2008 Results
...roduction of the newly
introduced Trilogy and D3 instruments, and increased reagent revenues
generated from Drew's United Kingdom facility."
"At our sonomed
business unit, product revenue decreased $203,000, or
7%, compared with the last fiscal year. This was primarily caused by an
increase in sales discou...
Escalon(R) Announces Promotion of Industry Veteran Barry Durante to President of Sonomed, Inc.
to Showcase Product Portfolio at the American Acad...ontinue to implement targeted growth strategies." sonomed
will showcase its industry-leading product portfol...eting, November 10 - 13, 2007,
in New Orleans, LA. sonomed
develops, manufactures and markets ultrasound